by Jen Thompson | Jan 21, 2025 | News
For years, midbodies were dismissed as mere cellular waste from cell division. But research is shifting this perspective! Recent studies reveal that midbodies and their remnants (MBRs) are dynamic assembly sites for RNA and active translation. These tiny structures...
by Jen Thompson | Jan 6, 2025 | News
MADISON, Wis., Jan. 6, 2025 /PRNewswire/ — In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 Pro™ antibodies, KIF23 gene – the same tools used by the world’s leading...
by Jen Thompson | Dec 10, 2024 | News
eMBR, an emerging biotechnology company focused on developing an accessible, non-invasive early-stage multi-cancer screening test using liquid biopsy, has been selected to join Forward Bio Labs’ latest cohort of innovative startups. This inclusion provides eMBR with...
